- £219.93m
- £405.10m
- £102.71m
- 48
- 87
- 30
- 56
C2019 January 31st | 2020 January 31st | 2021 January 31st | 2022 January 31st | 2023 January 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 83 | 89.9 | 83.8 | 87.9 | 103 |
Cost of Revenue | |||||
Gross Profit | 67.2 | 70.1 | 69.5 | 69.1 | 79 |
Selling / General / Administrative Expenses | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 43.9 | 50 | 62.1 | 37.1 | 53.8 |
Operating Profit | 39.1 | 40 | 21.7 | 50.8 | 48.9 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 34.6 | 35.1 | 18.1 | 47 | 41.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | 28 | 28.9 | 14.6 | 38 | 33.7 |
Net Income Before Extraordinary Items | |||||
Net Income | 28 | 28.9 | 14.6 | 38 | 33.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 28 | 28.9 | 14.6 | 38 | 33.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.32 | 2.39 | 1.21 | 3.13 | 2.78 |
Dividends per Share |